Related references
Note: Only part of the references are listed.Endothelial deficiency of L1 reduces tumor angiogenesis and promotes vessel normalization
Elena Magrini et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
L1CAM promotes enrichment of immunosuppressive T cells in human pancreatic cancer correlating with malignant progression
Evelin Grage-Griebenow et al.
MOLECULAR ONCOLOGY (2014)
RNA recognition by a human antibody against brain cytoplasmic 200 RNA
Euihan Jung et al.
RNA (2014)
Cholangiocarcinoma: Molecular Pathways and Therapeutic Opportunities
Sumera Rizvi et al.
SEMINARS IN LIVER DISEASE (2014)
L1 cell adhesion molecule and epidermal growth factor receptor activation confer cisplatin resistance in intrahepatic cholangiocarcinoma cells
Hyunho Yoon et al.
CANCER LETTERS (2012)
Combined treatment of L1CAM antibodies and cytostatic drugs improve the therapeutic response of pancreatic and ovarian carcinoma
Heiner Schaefer et al.
CANCER LETTERS (2012)
EMT-associated up-regulation of L1CAM provides insights into L1CAM-mediated integrin signalling and NF-κB activation
Helena Kiefel et al.
CARCINOGENESIS (2012)
A chimeric antibody to L1 cell adhesion molecule shows therapeutic effect in an intrahepatic cholangiocarcinoma model
Eung Suk Lee et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2012)
L1CAM Binds ErbB Receptors through Ig-Like Domains Coupling Cell Adhesion and Neuregulin Signalling
Emanuelle Donier et al.
PLOS ONE (2012)
L1CAM A major driver for tumor cell invasion and motility
Helena Kiefel et al.
CELL ADHESION & MIGRATION (2012)
Structural mechanism of the antigen recognition by the L1 cell adhesion molecule antibody A10-A3
Chun Hua Wei et al.
FEBS LETTERS (2011)
L1 cell adhesion molecule as a novel independent poor prognostic factor in gallbladder carcinoma
Song-Yi Choi et al.
HUMAN PATHOLOGY (2011)
Beyond natural antibodies: the power of in vitro display technologies
Andrew R. M. Bradbury et al.
NATURE BIOTECHNOLOGY (2011)
Recombinant antibody libraries and selection technologies
Heyue Zhou et al.
NEW BIOTECHNOLOGY (2011)
The cell adhesion molecule L1 promotes gallbladder carcinoma progression in vitro and in vivo
Juyeon Jung et al.
ONCOLOGY REPORTS (2011)
Therapeutic Antibodies to Human L1CAM: Functional Characterization and Application in a Mouse Model for Ovarian Carcinoma
Silke Wolterink et al.
CANCER RESEARCH (2010)
L1 Cell Adhesion Molecule Is a Novel Therapeutic Target in Intrahepatic Cholangiocarcinoma
Jeong-Ki Min et al.
CLINICAL CANCER RESEARCH (2010)
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer.
Juan Valle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
L1CAM-integrin interaction induces constitutive NF-κB activation in pancreatic adenocarcinoma cells by enhancing IL-1β expression
H. Kiefel et al.
ONCOGENE (2010)
L1 cell adhesion molecule (L1CAM) in invasive tumors
Shani Raveh et al.
CANCER LETTERS (2009)
L1 Cell Adhesion Molecule Is a Novel Independent Poor Prognostic Factor of Extrahepatic Cholangiocarcinoma
Shengjin Li et al.
CLINICAL CANCER RESEARCH (2009)
Novel anticancer targets: revisiting ERBB2 and discovering ERBB3
Jose Baselga et al.
NATURE REVIEWS CANCER (2009)
The differential role of L1 in ovarian carcinoma and normal ovarian surface epithelium
Silvia Zeechini et al.
CANCER RESEARCH (2008)
Kinetic analysis of L1 homophilic interaction - Role of the first four immunoglobulin domains and implications on binding mechanism
Ricardo M. Gouveia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Fibronectin type III (FN3) modules of the neuronal cell adhesion molecule L1 interact directly with the fibroblast growth factor (FGF) receptor
Nikolaj Kulahin et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2008)
Differential development of neuronal physiological responsiveness in two human neural stem cell lines
Roberta Donato et al.
BMC NEUROSCIENCE (2007)
Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells
S. Sebens Muerkoester et al.
ONCOGENE (2007)
Construction, affinity maturation, and biological characterization of an anti-tumor-associated glycoprotein-72 humanized antibody
SO Yoon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Efficient inhibition of intra-peritoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment
MJE Arlt et al.
CANCER RESEARCH (2006)
Isolating and engineering human antibodies using yeast surface display
Ginger Chao et al.
NATURE PROTOCOLS (2006)
L1, a novel target of β-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers
N Gavert et al.
JOURNAL OF CELL BIOLOGY (2005)
High-affinity human antibodies from phage-displayed synthetic fab libraries with a single framework scaffold
CV Lee et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer
D Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Extracellular signal-regulated kinase (ERK)-dependent gene expression contributes to L1 cell adhesion molecule-dependent motility and invasion
S Silletti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The L1CAM extracellular region: A multi-domain protein with modular and cooperative binding modes
J Haspel et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2003)
A new epitope tag from hepatitis B virus preS1 for immunodetection, localization and affinity purification of recombinant proteins
MS Oh et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2003)
Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins
S Mechtersheimer et al.
JOURNAL OF CELL BIOLOGY (2001)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
